Nephroprotection and early intervention support more planned dialysis starts, improved patient outcomes and increased use of home therapies, ...
Six studies were analyzed. Of the total 757 patients with gastric adenocarcinoma, 318 (42.0%) were stage I, 311 (41.0%) were stage II/III, 116 (15.3%) were stage IV, and 22 (2.9%) were undetermined.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results